DrugPatentWatch Database Preview

Drugs in Development Information for Tivozanib

« Back to Dashboard

Summary for Tivozanib

US Patents	15
International Patents	138
US Patent Applications	43
WIPO Patent Applications	26
Japanese Patent Applications	0
Clinical Trial Progress	Phase 3 (2009-12-01)
Vendors	70

US Patents for Tivozanib

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Tivozanib		Quinoline derivatives and quinazoline derivatives having azolyl group	Kirin Beer Kabushiki Kaisha (Tokyo-to, JP)
Tivozanib		N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxaz- olyl)urea salt in crystalline form	Kirin Beer Kabushiki Kaisha (Tokyo-To, JP)
Tivozanib		Quinoline derivatives and quinazoline derivatives having azolyl group	Kirin Beer Kabushiki Kaisha (Tokyo-To, KR)
Tivozanib		Tivozanib response prediction	AVEO Pharmaceuticals, Inc. (Cambridge, MA)
Tivozanib		Tivozanib response prediction	AVEO Pharmaceuticals, Inc. (Cambridge, MA)
Tivozanib		Tivozanib and temsirolimus in combination	AVEO Pharmaceuticals, Inc. (Cambridge, MA)

International Patents for Tivozanib

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Tivozanib	Austria	314361	2021-04-27
Tivozanib	Austria	396988	2021-04-27
Tivozanib	Australia	2002255284	2021-04-27
Tivozanib	Brazil	0209216	2021-04-27
Tivozanib	Brazil	PI0209216	2021-04-27
Tivozanib	Canada	2445333	2021-04-27